Presentation
Related topics:
MedTech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
Speaker
William C Maier
Chief Scientific Officer and Head of Patient-Centered Sciences
Mapi Group
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Global (non-specific), Life Sciences (not-specific)
Availability: FREE
- The revolution in our kitchen: The changing landscape of medical Affairs.
- Introducing new ingredients: A new blend of responsibility for medical affairs leaders.
- Prepare, mix, bake: Using the right approach to create an effective and affective medical affairs plan.
- Serving suggestions: How powerful communications can change patients’ lives.
Speakers
Ian Greenway
Medical Affairs Director
Complete HealthVizion, UK
Rhiannon Meaden
Head of Commercial Development
Complete HealthVizion, UK
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, IT & Big Data, Global (non-specific), Digital & Technology, Life Sciences (not-specific)
Availability: FREE
- Necessary conditions for better, more useful real-world data.
- Importance of a comprehensive and robust RWE strategy, including identification of optimal data sources, methods, and data gaps.
- The use of technology in data analytics for increased cost savings and decreased time for results
Speaker
Radek Wasiak
Vice President, Meta Research & Real-World Evidence,
Evidera Inc., UK
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific), Regulations & Ethics, Life Sciences (not-specific)
Availability: FREE
- Regulatory classification of real-world studies.
- Why are the regulations for non-interventional studies so difficult/frustrating/confusing?
- Pragmatic clinical trials: The missing RWE link?
Speaker
Stuart McCully
VP Late Stage
INC Research/inVentiv Health, UK
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific), Life Sciences (not-specific)
Availability: FREE
- Post-marketing commitments: PASS, PAES.
- Article 20s and DUS: Prospective or retrospective data.
- ENCePP: How to make the most of it.
- Leveraging innovation to meet commitments.
- Real World Evidence 3.0.
Speaker
Alexandre Malouvier
Director of Scientific Affairs, Late Phase Services
PRA Health Sciences, UK
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Global (non-specific), Life Sciences (not-specific)
Availability: FREE
- Why medical affairs must adapt and consider this educational format to engage physicians.
- What is the value of IME?: Benefits and considerations in funding IME/CME.
- Interactive case study of IME, identifying best practices to providing IME/CME.
Speaker
Celeste Kolanko
Managing Director
Liberum IME, UK
Presentation
Related topics:
Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific), Life Sciences (not-specific)
Availability: FREE
- Regulator and payer perspectives on patient-centric data in decision making.
- Highly successful strategies for leveraging the patient voice in RWE research.
Speakers
Leanne Larson
Corporate VP, Observational Research
PAREXEL
Oliver Leatham
VP Heron Commercialization
PAREXEL
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Global (non-specific), Patient-Centricity & Care, Life Sciences (not-specific)
Availability: FREE
- Identify key questions that should be asked when determining if medical communications are meaningful for patients.
- Working with stakeholders to provide insights for patient-centric communications.
- Describe two case studies that demonstrate how medical communications to patients were vastly improved by applying patient insights.
Speaker
William C Maier
Chief Scientific Officer and Head of Patient-Centered Sciences
Mapi Group
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Life Sciences (not-specific)
Availability: FREE
- Transformation of medical affairs to deliver greater value.
- Executing long term engagement strategies in today’s complex disease space.
- Developing and delivering scientific insights to achieve strategic differentiation.
Speaker
Sital Kotecha
Director, Medical Strategy
Veeva Systems, UK